Skip to Content
Breast Tumor Proteomics

Computational Omics Funding Opportunity

Up to $2 million dollars is available for projects that use publicly available computational omics to better understand cancer.

For more information, click here.

Clinical Proteomic Tumor Analysis Consortium

The National Cancer Institute (NCI), part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium (CPTAC) in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. Read more.  

Publications

  • Xu Z, Wu C, Xie F, Slysz GW, Tolić N, Monroe ME, Petyuk VA, Payne SH, Fujimoto GM, Moore RJ, Fillmore TL, Schepmoes AA, Levine DA, Townsend RR, Davies SR, Li S, Ellis M, Boja E, Rivers R, Rodriguez H, Rodland KD, Liu T, Smith RD. (2014) Comprehensive Quantitative Analysis of Ovarian and Breast Cancer Tumor Peptidomes. J Proteome Res. Epub ahead of print . View PubMed abstract..
  • Yang J, Gupta V, Carroll KS, Liebler DC. (2014) Site-specific mapping and quantification of protein S-sulphenylation in cells. Nat Commun. 5 1-12.
  • Sharma V, Eckels J, Taylor GK, Shulman NJ, Stergachis AB, Joyner SA, Yan P, Whiteaker JR, Halusa GN, Schilling B, Gibson BW, Colangelo CM, Paulovich AG, Carr SA, Jaffe JD, MacCoss MJ, MacLean B. (2014) Panorama: a targeted proteomics knowledge base. J Proteome Res. 13 (9): 4205-10. View PubMed Abstract.

View All »